2017 year 5 month 5 On [date], the Third National Academic Conference on Clinical Laboratory Equipment Technology and Applications, hosted by the Laboratory Medicine Branch of the China Association for Medical Device Industry, was held… SAC/TC136 The Summit Forum and the Third National Clinical Laboratory Equipment Exhibition were held as scheduled at the Changsha International Convention and Exhibition Center.

This conference is themed around “ Precision, green, and intelligent ” Integrating medical devices under the conference theme. “ Industry, academia, research, and application ” The event provides a platform for domestic and international enterprises to engage in mutual exchange, learn from one another, and achieve shared development. In addition, the conference hosts numerous academic sessions and forums, offering in-depth discussions and knowledge sharing on cutting-edge technologies and groundbreaking advances in clinical laboratory diagnostics, thereby fostering the continued growth of the laboratory medicine sector.

Dier Biotech showcased a range of automated instruments and accompanying reagents for infectious disease diagnostics, including bacterial morphology analysis, bacterial culture, identification, and in vitro antimicrobial susceptibility testing. Among them, DL-96A The bacterial identification and antimicrobial susceptibility testing system is a fully automated platform independently developed by Dier Biotechnology and protected by national patents. With its market launch, it has broken the monopoly of imported products in this fully automated segment and fully meets the requirements for antimicrobial susceptibility testing. CLSI and CRASS the requirements; DL-GBS Series B The group A streptococcus culture analysis system employs a liquid chromogenic culture method and automated instrumentation for detection, providing targeted solutions. B The need for high-throughput, highly accurate prenatal screening of group B streptococcus has attracted widespread attention from experts and educators.

The microbial sub-forum has outlined the emerging trends in microbiological testing, namely: “ Precise, fast, and intelligent ” Dier will continue to intensify its R&D efforts and academic investments, making due contributions to promoting the rational use of antibiotics and curbing the emergence of drug-resistant bacteria.